Plasminogen activator inhibitor-1 (PAI-1) and urokinase plasminogen activator (uPA) in sputum of allergic asthma patients

Folia Histochemica et Cytobiologica

Volumn 46, Issue 2, 2008, Pages 193-198

  Kowal, Krysztof ^a   Zukowski, Sebastian ^a   Moniuszko, Marcin ^a   Bodzenta Łukaszyk, Anna ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Allergen challenge; Asthma; Plasminogen activator inhibitor

Indexed keywords

HISTAMINE; NITRIC OXIDE; PLASMINOGEN ACTIVATOR INHIBITOR 1; UROKINASE;

ADULT; ALLERGIC ASTHMA; ARTICLE; BRONCHUS REACTIVITY; CELL COUNT; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FORCED EXPIRATORY VOLUME; HOUSE DUST ALLERGY; HUMAN; MALE; SPUTUM ANALYSIS; ADOLESCENT; ANIMAL; ASTHMA; DERMATOPHAGOIDES PTERONYSSINUS; IMMUNOLOGY; INFLAMMATION; LUNG FUNCTION TEST; METABOLISM; PARASITOLOGY; PATHOPHYSIOLOGY; SPUTUM;

PYROGLYPHIDAE;

ADOLESCENT; ADULT; ANIMALS; ASTHMA; DERMATOPHAGOIDES PTERONYSSINUS; FEMALE; HUMANS; INFLAMMATION; MALE; PLASMINOGEN ACTIVATOR INHIBITOR 1; RESPIRATORY FUNCTION TESTS; SPUTUM; URINARY PLASMINOGEN ACTIVATOR;

EID: 48449103440     PISSN: 02398508     EISSN: None     Source Type: Journal    
DOI: 10.2478/v10042-008-0029-0     Document Type: Article

References (25)

1. Amin K, Ludviksdottir D, Janson C, Nettelbladt O, Bjornsson E et al. Inflammation and structural changes in the airways of patients with atopic and nonatopic asthma. Am J Respir Crit Care Med. 2000;162:2295-2301.
2. Busse W, Elias J, Sheppard D, Banks-Schelegel A. Airway remodeling and repair. Am J Respir Crit Care Med. 1999;160:1035-42.
3. Laitinen LA, Laitinen A, Haahtela T. Airway mucosal inflammation even in patients with newly diagnosed asthma. Am Rev Respir Dis. 1993;147:697-704.
4. Jeffery PK, Wardlaw AJ, Nelson FC, Collins JV, Kay AB. Bronchial biopsies in asthma: an ultrastructural, quantitative study and correlation with hyper reactivity. Am Rev Respir Dis. 1989;140:1745-53.
5. Chetta A, Foresi A, Del Donno M, Bertorelli G, Pesci A, Olivieri D. Airway remodeling is a distinctive feature of asthma and is related to severity of asthma. Chest. 1997;111:852-857.
6. Binder BR, Christ G, Gruber F, Grubic N, Hufnagl P, Krebs M et al. Plasminogen activator inhibitor 1: Physiological and pathophysiological roles. News Physiol Sci. 2002;17:56-61.
7. Kucharewicz I, Kowal K, Buczko W, Bodzenta-Lukaszyk A. The plasmin system in airway remodeling. Thromb Res. 2003;112:1-7.
8. Oh CK, Ariue B, Alban RF, Shaw B, Cho SH. PAI-1 promotes extracellular matrix deposition in the airways of a murine asthma model. Biochem Biophys Res Commun. 2002;294:1155-60.
9. Cho SH, Ryu CH, Oh CK. Plasminogen activator inhibitor-1 in the pathogenesis of asthma. Exp Biol Med (Maywood). 2004;229:138-46.
10. Cho SH, Tam SW, Demissie-Sanders S, Filler SA, Oh CK. Production of plasminogen activator inhibitor-1 by human mast cells and its possible role in asthma. J Immunol. 2000; 165:3154-61.
11. Gyetko MR, Sud S, Chensue SW. Urokinase-deficient mice fail to generate a type 2 immune response following Schistosomal antigen challenge. Infect Immunn. 2004;72:461-7.
12. Banach-Wawrzeńczyk E, Dziedziczko A, Rość D. Fibrynolysis system in patients with bronchial asthma. Med Sci Monit 2000;6:103-7.
13. Banach-Wawrzeńczyk E, Dziedziczko A, Rość D Fibrynolytic system in bronchial asthma after prednisone treatment. Pol Merk Lek. 2000;7:9-11.
14. Cho SH, Hall IP, Wheatley A, Dewar J, Abraha D, Del Mundo J et al. Possible role of the 4G/5G polymorphism of the plasminogen activator inhibitor 1 gene in the development of asthma. J Allergy Clin Immunol. 2001;108:212-14.
15. Pampuch A, Kowal K, Bodzenta-Lukaszyk A, Di Castelnuovo A, Chyczewski L, Donati MB, Iacoviello L. The -675 4G/5G plasminogen activator inhibitor-1 promoter polymorphism in house dust mite-sensitive allergic asthma patients. Allergy. 2006;61:234-8.
16. Kowal K, Bodzenta-Lukaszyk A, Pampuch A, Szmitkowski M, Zukowski S et al. The -675 4G/5G plasminogen activator inhibitor -1 (PAI-1) and C-159T CD14 polymorphisms in house dust mite allergic asthma patients. J Invest Allergol Clin Immunol. 2008;18:in press.
17. Begin P, Tremblay K, Daley D, Lamire M, Claveau S et al. Association of urokinase-type plasminogen activator with asthma and atopy. Am J Respr Crit Care Med. 2007;175: 1109-16.
18. Kowal K, Osada J, Zukowski S, Dabrowska M, DuBuske LM, Bodzenta-Lukaszyk A. Expression of interleukin-4 receptor in bronchial asthma patients treated with specific immunotherapy (SIT). Ann Allergy Asthma Immunol. 2004; 93:68-75.
19. Kowal K, Moller HJ, DuBuske LM, Moestrup SK, Bodzenta-Lukaszyk A. Differential expression of monocyte CD163 in single- and dual-asthmatic responders during allergen-induced bronchoconstriction. Clin Exp Allergy. 2006;36: 1584-91.
20. Popov TA, Pizzichini MMM, Pizzichini E, Kolendowicz R, Punthakee Z, Dolovich J, Hargreave FE. Some technical factors influencing the induction of sputum for cell analysis. Eur Respir J. 1995;8:559-565.
21. Moniuszko M, Bodzenta-Lukaszyk A, Kowal K, Dabrowska M. Bronchial macrophages in asthmatics reveal decreased CD16 expression and substantial levels of receptors for IL-10 but not IL-4 and IL-7. Folia Histochem Cytobiol. 2007;45: 181-9.
22. Kowal K, Bodzenta-Lukaszyk A, Pampuch A, Szmitowski M, Donati MB, Iacoviello L. Plasminogen activator inhibitor-1 plasma concentration in allergic asthma patients during alergen challenge. Int Arch Allergy Immunol. 2007;144:240-6.
23. Ciao W, Hsu YP, Ishizaka A, Kirikae, Moss RB. Sputum cathelicidin, urokinase plasminogen system components and cytokine discriminate cystic fibrosis, COPD and asthma inflammation. Chest. 2005;128:2316-26.
24. Hattori N, Degen JL, Sisson TH, Liu H, Moore BB et al. Bleomycin-induced pulmonary fibrosis in fibrinogen-null mice. J Clin Invest. 2000;106:1341-50.
25. Brooks AM, Bates ME, Vrtis RF, Jarjour NN, Bertics PJ, Sedgwick JB. Urokinase-type plasminogen activator modulates airway eosinophil adhesion in asthma. Am J Respir Cell Mol Biol. 2006;35:503-11.